mobile menu icon

Real estate and life sciences


Bristows has a world class reputation for representing clients in this fast moving sector and provides a breadth of multi-disciplinary legal skills for clients ranging from multinational pharmaceutical companies and medical device companies to university and technology start-ups.

From bespoke laboratory buildings through to campus collaborations and technology clusters, our experienced real estate team works at finding bespoke solutions to our clients’ needs.  We provide sensible, commercial and innovative advice on acquisitions and disposals through to the process of releasing capital by disposal of surplus property for redevelopment and everything in between.
We also pride ourselves on our ability to provide strategic support and guidance to our clients as they contemplate the rationalisation of their real estate portfolios enabling the organisation to focus on making the right operational decisions.

Recent experience includes:

  • Advising on the real estate aspects relating to the provision of a sequencing centre for the analysis of DNA as part of a commercial contract to deliver the high profile, government backed, ‘100,000 Genomes Project’- the biggest project of its kind in the world
  • Acting for a global research-based bio-pharmaceutical company on the disposal of a UK manufacturing facility as part of a business disposal to a US operator
  • Acting on behalf of a medical technology company on its acquisition and complex fit out of new premises on a business park and a subsequent lease restructuring to provide offices, laboratory and a research and development facility
  • Advising a science driven contract research organisation developing preclinical and early phase formulations and the manufacture of clinical trials materials on its investment in new facilities
  • Advising an AIM listed company providing clinical trials services and technology on its property holding and business relocation
  • Advising on the real estate aspects of a joint venture for the development of new diagnostic tools between a specialist medical diagnostics company and a leading university
Share to: